Egetis Therapeutics AB (publ) (STO: EGTX)
Sweden
· Delayed Price · Currency is SEK 5.34
-0.06 (-1.11%)
Nov 22, 2024, 5:22 PM CET
Egetis Therapeutics AB Market Cap
Egetis Therapeutics AB has a market cap or net worth of 1.92 billion as of November 22, 2024. Its market cap has increased by 33.54% in one year.
Market Cap
1.92B
Enterprise Value
1.90B
Revenue
67.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.34
Market Cap Chart
Since April 7, 2011, Egetis Therapeutics AB's market cap has increased from 224.89M to 1.92B, an increase of 753.00%. That is a compound annual growth rate of 17.03%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca PLC | 2,158.07B |
| Swedish Orphan Biovitrum AB (publ) | 99.53B |
| Sectra AB (publ) | 52.53B |
| Getinge AB (publ) | 45.40B |
| Camurus AB (publ) | 32.34B |
| Vitrolife AB (publ) | 28.41B |
| Medicover AB (publ) | 26.03B |
| Elekta AB (publ) | 23.73B |